EDBI
VC Fund
Singapore, Singapore
EDBI is a VC fund in Singapore focused on Software and Biotechnology. Investing since 1991, EDBI is a Singapore-based global investor in select high-growth technology sectors ranging from Information and Communication Technology (ICT), Emerging Technology (ET), Healthcare (HC), and other strategic industries. As a value-creating investor, EDBI assists companies to achieve their ambitious goals by leveraging their broad network, resources, and expertise. With their patient capital, EDBI supports companies seeking to grow in Asia and globally through Singapore.
- Total investments:
- 204
- Last investment:
- Lead investor:
- 22%
Last updated:
For AI agents: llms.txt
Industries EDBI invests in
Stages EDBI invests in
Countries EDBI invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Series B
- $19M–$170M
- Series C
- $10M–$275M
- Series D
- $17M–$400M
Investment Focus
Industry
- Software 38 (19%)
- Biotechnology 37 (18%)
- Health Care 32 (16%)
- Artificial Intelligence 25 (12%)
- Information Technology 19 (9%)
Stage
- Series C 46 (23%)
- Series B 31 (15%)
- Series D 28 (14%)
- Series A 24 (12%)
- Venture - Series Unknown 13 (6%)
Country
- United States 87 (43%)
- Singapore 46 (23%)
- United Kingdom 5 (2%)
- India 4 (2%)
- China 3 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Chu Swee Yeok
CEO and President
|
CEO and President | Total investments: 26 | Find email | |
Jolene Ooi
Senior Principal
|
Senior Principal | Total investments: 2 | Find email | |
|
Lawrence Low
Senior Vice President, Investments
|
Senior Vice President, Investments | Total investments: 2 | Find email | |
Paul Ng
Managing Partner; Chief Executive Officer
|
Managing Partner; Chief Executive Officer | Total investments: 5 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Universal Quantum is building quantum computers to tackle real-world problems that would take today’s fastest supercomputers billions of years to solve. | $100M / Series A / Oct 08, 2026 | ||
| Universal Quantum is building quantum computers to tackle real-world problems that would take today’s fastest supercomputers billions of years to solve. | Venture - Series Unknown / Sep 09, 2026 | ||
| Deepgram helps enterprises unlock the potential of their audio data with custom-trained speech recognition for accuracy and scale. Deepgram's deep learning speech recognition system searches for keywords in transcripts by sound and text within audio and video files, used for transcribing calls, meetings, and voicemails for searchable notes,providing businesses with a fast, high accuracy speech-to-text on an easy-to-use API.The company was founded in 2015 and is headquartered in San Francisco, California. | Series C / Aug 18, 2026 | ||
| Horizon3.ai's mission is to help you find and fix your attack vectors before criminals exploit them. NodeZero, our automated penetration testing solution, enables organizations to continuously assess the security posture of their enterprise, including external, identity, on-prem, IoT, and cloud attack surfaces. Like APTs, ransomware, andother threat actors, our algorithms discover and fingerprint your attack surface, identifying the ways exploitable vulnerabilities, misconfigurations, harvested credentials, and dangerous product defaults can be chained together to facilitate a compromise. NodeZero is a true self-service SaaS offering that is safe to run in production and requires no persistent or credentialed agents. You will see your enterprise through the eyes of the attacker, identify your ineffective security controls, and ensure your limited resources are spent fixing problems that can actually be exploited. Founded in 2019 by industry, US Special Operations, and US National Security veterans, Horizon3.ai is headquartered in San Francisco, CA, and made in the USA. | $250M / Series E / Aug 03, 2026 | ||
| HyperLight provides thin-film lithium niobate photonic integrated circuit solutions. They deliver groundbreaking electro-optic and nonlinear optical solutions with scalable manufacturing processes. They work closely with their customers from conceptualization, design, prototyping, and transfer to volume production. | $80M / Series C / Jun 18, 2026 | ||
| Silicon Box is an advanced OSAT (outsourced semiconductor assembly and testing) services provider, specializing in semiconductor integration. The company is capable of delivering full execution for semiconductor packaging, from initial design to final manufacturing of standard single chip packages to the most sophisticated chiplet-based systems,enabling applications that include AI (artificial intelligence), HPC (high performance computing), EV (electric vehicles), automotive, power management, mobile chipsets and processors, applications processors, radiofrequency, and more. | $155M / Series B / May 12, 2026 | ||
| Iterative Health is a healthcare technology and services company that focuses on accelerating clinical research to improve patient outcomes through innovative approaches. The company transforms gastrointestinal (GI) care by utilizing AI-driven clinical trials and diagnostics, significantly enhancing access to vital treatments. | $77M / Series C / Apr 30, 2026 | ||
| Amity is a Technology Holding & Investment Company focused on the AI-Driven Future of Customer Experience. Porfolio companies include: Amity Solutions, Tollring, Social+, Amity Accentrix and Amity Robotics. | $100M / Series D / Mar 25, 2026 | ||
| CesiumAstro delivers communication systems for satellites, UAVs, launch vehicles, and other space or airborne platforms. Each of the company's products combines carefully selected COTS components with the traditional reliability necessary for aerospace systems. Its products enable connectivity between satellites, drones, planes, cars, andother mobile devices and generate electronically steerable beams of radio waves carrying information between the devices, and its software stitches the information together. | $270M / Series C / Feb 02, 2026 | ||
| Cellares develops and operates integrated technologies for automated cell therapy manufacturing and quality control that help biopharmaceutical partners scale development to industrial production. The company’s offerings include the Cell Shuttle platform for end-to-end automation of the cell therapy manufacturing process and the Cell Q platform forautomated quality control, supported by integrated software and consumable cartridges. Cellares positions itself as an Integrated Development and Manufacturing Organization that supports process transfer, scalable production, and regulatory pathways for clinical and commercial programs. Its services enable clients to transition manual processes onto automated systems and expand manufacturing capacity to meet broader patient demand. | $257M / Series D / Jan 28, 2026 | ||
| See all 204 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does EDBI invest in?
EDBI invests primarily in Software, Biotechnology and Health Care startups, most often at Series C and Series B stage. Most of the 204 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is EDBI's check size?
EDBI typically joins rounds of $19M–$170M at Series B, $10M–$275M at Series C and $17M–$400M at Series D. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds EDBI participates in.
How do I contact EDBI?
Public channels for EDBI include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at EDBI?
The team at EDBI includes Chu Swee Yeok (CEO and President), Jolene Ooi (Senior Principal) and Lawrence Low (Senior Vice President, Investments). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
